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Reliability and Physiological Interpretation of Pulmonary Gas
Exchange by “Circulatory Equivalents” in Chronic Heart Failure
Chunting Tan, MD, PhD; Harry B. Rossiter, PhD; Janos Porszasz, MD, PhD; T. Scott Bowen, PhD; Klaus K. Witte, MD; William W. Stringer,
MD; Richard Casaburi, PhD, MD; James E. Hansen, MD2,†
Background-—Peak ratios of pulmonary gas-exchange to ventilation during exercise ( _VO2= _VE and _VCO2= _VE, termed “circulatory
equivalents”) are sensitive to heart failure (HF) severity, likely reﬂecting low and/or poorly distributed pulmonary perfusion. We
tested whether peak _VO2= _VE and _VCO2= _VE would: (1) distinguish HF patients from controls; (2) be independent of incremental
exercise protocol; and (3) correlate with lactate threshold (LT) and ventilatory compensation point (VCP), respectively.
Methods and Results-—Twenty-four HF patients (6111 years) with reduced ejection fraction (318%) and 11 controls
(637 years) performed ramp-incremental cycle ergometry. Eighteen HF patients also performed slow (51 W/min), medium
(94 W/min), and fast (196 W/min) ramps. Peak _VO2= _VE and _VCO2= _VE from X-Y plot, and LT and VCP from 9-panel plot, were
determined by 2 independent, blinded, assessors. Peak _VO2= _VE (31.24.4 versus 41.84.8 mL/L; P<0.0001) and _VCO2= _VE
(29.33.0 versus 36.94.0 mL/L; P<0.0001) were lower in HF than controls. Within individuals, there was no difference across 3
ramp rates in peak _VO2= _VE (P=0.62) or _VCO2= _VE (P=0.97). Coefﬁcient of variation (CV) in peak _VO2= _VE was lower than for LT
(5.12.1% versus 8.23.7%; P=0.014), and coefﬁcient of variation in peak _VCO2= _VE was lower than for VCP (3.31.8% versus
8.74.2%; P<0.001). In all participants, peak _VO2= _VE was correlated with, but occurred earlier than, LT (r2=0.94; mean bias,
0.11 L/min), and peak _VCO2= _VE was correlated with, but occurred earlier than, VCP (r2=0.98; mean bias 0.08 L/min).
Conclusions-—Peak circulatory equivalents during exercise are strongly associated with (but not identical to) LT and VCP. Peak
circulatory equivalents are reliable, objective, effort-independent indices of gas-exchange abnormality in HF. ( J Am Heart Assoc.
2018;7:e008072. DOI: 10.1161/JAHA.117.008072.)
Key Words: cycle ergometry • heart failure • incremental exercise • lactate threshold • ventilatory compensation
C hronic heart failure (HF) is characterized by dyspnea onexertion and exercise intolerance.1 HF remains a
progressive disease, and the associated exercise intolerance
is the strongest correlate of morbidity and mortality.2–4 Peak
oxygen uptake ( _VO2peak),
5 end-tidal gas tensions,6 and
oscillatory breathing7,8 measured by cardiopulmonary
exercise testing (CPET) are prognostic of mortality in HF,
and _VO2peak and lactate threshold (LT) are used for risk
stratiﬁcation, such as to guide suitability for transplant.4,9–11
The relationship between ventilation ( _VE) and carbon dioxide
output ( _VCO2) (either as the _VE= _VCO2 slope, or the value of
_VE= _VCO2 at a speciﬁed submaximal metabolic rate; eg, at LT
or the ventilatory compensation point [VCP]), typically
provides one of the strongest prognosticators,12–14 either
independently or in combination with other CPET and non-
CPET variables.15,16
Recently, the ratios of pulmonary gas exchange to
ventilation ( _VO2= _VE and _VCO2= _VE, termed circulatory equiv-
alents) have been added to the list of CPET-derived variables.
By placing ventilation in the denominator, these “circulatory
equivalents” (so called, because of the mechanistic depen-
dence on pulmonary blood ﬂow for O2 and CO2 exchange)
reﬂect the rate of pulmonary gas exchange accomplished at a
given level of ventilation. Hansen et al17 demonstrated the
sensitivity of circulatory equivalents to distinguish HF severity
using a plot that presents _VO2= _VE versus _VCO2= _VE on equal
X-Y axes. The response proﬁles of this graphical representa-
tion from rest, exercise, and recovery provide a simple
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visualization of the normalcy (or otherwise) of gas exchange: a
large “open” curve with greater peak values represents
greater aerobic capacity and greater ventilatory efﬁciency
than a “narrow” curve with lower peak values (eg, see
Figure 1B and 1D). The peak values of the _VO2= _VE and
_VCO2= _VE ratios are effort-independent quotients that occur
submaximally and therefore do not depend on maximal effort
during a symptom limited test. Objectively measured peak
circulatory equivalents stratify severity in HF.17
The physiological processes that determine peak circula-
tory equivalents, however, have not been established. Break
points in ventilatory equivalents (the inverse of circulatory
equivalents) are used to inform the noninvasive estimation of
LT and VCP.9,18,19 We therefore aimed to establish the
association between peak _VO2= _VE and LT and peak _VCO2= _VE
and VCP during ramp-incremental exercise in HF. Association
among these variables would support the physiological
constructs underpinning the proﬁle of the circulatory equiv-
alent X-Y plot.17
It is well established that peak _VCO2 and _VE responses to
incremental exercise differs in response to fast, medium, and
slow ramp-incremental tests in HF, whereas LT and peak _VO2
do not.20,21 Therefore, to assess the robustness of peak
circulatory equivalents, we measured these variables using
fast (lasting 5 minutes before intolerance), medium
(10 minutes), and slow (15 minutes) ramp-incremental
tests. We reasoned that should peak _VO2= _VE and _VCO2= _VE
represent LT and VCP (epoch events in an individual’s aerobic
range), then they should be unaffected by different ramp-
incremental protocols: A low variability would support the
reliability of circulatory equivalents to detect abnormality,
where it occurs, independently of the exercise testing
protocol.
We therefore tested the hypotheses that the peak _VO2= _VE
and _VCO2= _VE values during ramp-incremental exercise would:
(1) distinguish HF patients from age-matched controls, as
previously shown; (2) be independent of incremental exercise
protocol within the same patients; and (3) correlate with LT
and VCP, respectively.
Methods
The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
Participants
Retrospective analysis was conducted on de-identiﬁed data
from 24 male HF patients (Weber class22 A/B/C/D n=1/6/
15/2) and 11 age-matched controls (Table 1). LT and peak
exercise physiological responses of the HF group21 and some
(n=9) of the control group23 were published previously. Data
were chosen on the basis that participants had performed 3
different ramp-incremental protocols resulting in intolerance
in 5, 10, and 15 minutes, or were age- and sex-matched
Figure 1. Ratios of ventilation and pulmonary gas exchange
during ramp-incremental exercise in heart failure and controls. A,
Ventilatory equivalents ( _VE= _VO2 and _VE= _VCO2) in a healthy subject
plotted against time using a 90-second rolling average. B,
Circulatory equivalents ( _VO2= _VE and _VCO2= _VE) in a healthy subject,
using the same data as in (A), plotted in an X-Y plot arrangement. C,
Ventilatory equivalents ( _VE= _VO2 and _VE= _VCO2) in a heart failure
patient plotted against time using a 90-second rolling average. D,
Circulatory equivalents ( _VO2= _VE and _VCO2= _VE) in a heart failure
patient, using the same data as in (C), plotted in an X-Y plot
arrangement. Red dots indicate the point of identiﬁcation of the
lactate threshold or peak _VE= _VO2. Green dots indicate the point of
identiﬁcation of the ventilatory compensation point or peak
_VE= _VCO2. LT indicates lactate threshold; _VCO2, carbon dioxide
output; VCP, ventilatory compensation point; _VE, expired ventila-
tion; _VO2, oxygen uptake.
Clinical Perspective
What Is New?
• The physiological basis, and sensitivity to exercise testing
protocol, of peak ratios of pulmonary gas exchange to
ventilation during exercise ( _VO2= _VE and _VCO2= _VE)—termed
“circulatory equivalents”—were investigated in heart failure
and controls.
What Are the Clinical Implications?
• Peak circulatory equivalents are reliable, objective, effort-
independent indices of gas-exchange abnormality in heart
failure, which may help to simplify interpretation of
cardiopulmonary exercise testing results.
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controls. HF participants were in a stable condition and on
optimized therapy (angiotensin-converting enzyme inhibitors
[n=22], aspirin [n=17], b-blocker [n=22], digoxin [n=4],
furosemide [n=19], spironolactone [n=18], and statin
[n=18]). None showed evidence of exercise oscillatory
ventilation. Control participants were recruited for previous
studies in our lab to be free of pulmonary, neuromuscular,
metabolic, and skeletal disorders or signiﬁcant anemia. All
participants gave written informed consent to participate in
the original research studies at the Faculty of Biological
Sciences, University of Leeds, or at Los Angeles Biomedical
Research Institute at Harbor-UCLA Medical Center. Institu-
tional ethical or review boards approved all studies.
Exercise Testing
Participants undertook ramp-incremental exercise on a cycle
ergometer (Excalibur Sport; Lode BV, Groningen, The Nether-
lands). Eighteen HF patients each performed 3 tests using
slow (51 W/min), medium (94 W/min), and fast
(196 W/min) ramps resulting in endurance times of 5,
10, and 15 minutes. An additional 6 HF patients and 11
controls underwent a ramp-incremental exercise test to
intolerance in 10 minutes (73 and 226 W/min, respec-
tively). Breath-by-breath gas exchange, ventilatory, and
cardiac variables were measured by metabolic cart (MSX;
nSpire Health, Hertford, UK or Vmax; Carefusion, Yorba Linda,
CA). During exercise tests, participants initially sat at rest on
the cycle ergometer for 3 minutes, followed by 3 minutes
of unloaded cycling, ramp-incremental exercise to symptom-
limited peak, and unloaded active recovery for 5 minutes.
Data Processing
Data were processed and displayed in 3 different ways using
Sigma Plot (version 13.0; Systat Software Inc., Chicago, IL).
Initially, breath-by-breath data were averaged into 30 bins and
plotted in a standard “9-panel” CPET report format for
estimation of LT and VCP by standard gas exchange and
ventilatory criteria.24 LT and VCP were identiﬁed by 2
reviewers independently. _VO2peak is reported as the peak
30-second average during exercise. Second, breath-by-breath
data were subject to 90-second rolling average and were
assessed again using the 9-panel report, in a blinded fashion,
for veriﬁcation that the longer averaging window (that was
subsequently used for circulatory equivalent analyses) had no
inﬂuence on the LT and VCP estimation. Finally, 90-second
rolling average plots of _VO2= _VE-versus- _VCO2= _VE (the X-Y plot)
were produced. LT and VCP (from 9-panel) and peak _VO2= _VE
and _VCO2= _VE (from X-Y plot) were assessed by the same 2
assessors blinded to the group and condition. The _VO2 at
each of the 4 discrete points was identiﬁed for direct
comparison among graphical analysis methods.
Statistical Analysis
Comparison of variables (LT, VCP, _VO2peak, _VO2= _VE, and
_VCO2= _VE) between patients and controls was made using the
Mann–Whitney U test. The Kruskal–Wallis test was used to
compare the effect of protocol (ramp-incrementation rate) on
LT, VCP, _VO2peak, peak _VO2= _VE, and peak _VCO2= _VE in 18
congestive heart failure patients. Agreement between the 9-
panel and X-Y graphical methods to identify physiological
thresholds (LT and VCP) was assessed in 24 patients and 11
controls using Bland-Altman analysis. All analyses were
performed using IBM SPSS Statistics software (version 20.0;
SPSS 20; IBM Corp., Armonk, NY). Data are presented as
meanSD. Statistical signiﬁcance was accepted at P<0.05.
Results
Participant Characteristics
Characteristics of HF patients and controls are summarized in
Table 1. No signiﬁcant difference was found in age, height, or
weight between 24 HF patients and 11 controls.
LT, VCP, and _VO2peak in HF and Controls
We found no signiﬁcant difference in LT (0.030.05 L/min;
P=0.172) or in VCP (0.010.04 L/min; P=0.398) between
30- and 90-second averaging methods, hence the values
using the 90-second rolling average are reported for consis-
tency of comparison with circulatory equivalents. Figure 1
shows examples of LT and VCP detection for a representative
control (Figure 1A) and HF patient (Figure 1C). As expected
LT, VCP, and _VO2peak were signiﬁcantly lower in HF than
controls (Table 2). However, within HF patients, there was no
Table 1. Participant Characteristics
Heart Failure (n=24) Controls (n=11)
Age, y 6411 637
Sex, M/F 24/0 9/2
Height, cm 1727 1708
Weight, kg 8816 8012
Peak _VO2, mL/min per kg 14.23.0 31.88.3
NYHA functional class, I/II/III/IV 4/19/1/0 
Etiology of CHF, IHD/DCM 16/8 
LVEF, % 318 
Data are presented as meanSD. CHF indicates congestive heart failure; DCM, dilated
cardiomyopathy; IHD, ischemic heart disease; LVEF, left ventricular ejection fraction;
NYHA, New York Heart Association.
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signiﬁcant effect of protocol (ramp-incrementation rate) on
the estimates of LT (P=0.816), VCP (P=0.894), and _VO2peak
(P=0.476).
Circulatory Equivalents in HF and Controls
Figure 1 shows examples of peak _VO2= _VE and peak _VCO2= _VE
detection for a representative control participant (Figure 1B)
and HF patient (Figure 1D). The peak _VO2= _VE (31.24.4
versus 41.84.8 mL/L; P<0.0001) and peak _VCO2= _VE
(29.33.0 versus 36.94.0 mL/L; P<0.0001) were lower in
HF than controls (Figure 2A and 2B). Within individuals, there
was no signiﬁcant effect of protocol on peak _VO2= _VE (P=0.62)
or _VCO2= _VE (P=0.97; Table 3). However, among different
ramp-incrementation rates in HF, the coefﬁcient of variation
(%) for estimation of peak _VO2= _VE by X-Y plot was signiﬁcantly
lower than the coefﬁcient of variation for LT estimation using
the 9-panel plot (5.12.1% versus 8.23.7%; P=0.014;
Figure 2C). Similarly, peak _VCO2= _VE from the X-Y plot was
Table 2. LT, VCP and Peak Oxygen Uptake (VO2peak) in HF
Patients and Controls Determined Noninvasively Using the 9-
Panel Plot
LT (L/min) VCP (L/min) _VO2peak (L/min)
Control (n=11,
medium ramp)
1.550.56 2.060.71 2.580.84
HF (n=24, medium
ramp)
0.810.18* 1.010.26* 1.280.34*
HF (n=18, different ramp protocols)
Slow ramp 0.830.16 1.040.18 1.290.30
Medium ramp 0.820.15 1.020.20 1.280.30
Fast ramp 0.840.14 1.040.18 1.320.26
Data are presented as meanSD.
*P<0.001 HF vs control for the same ramp protocol (medium).
HF indicates heart failure; LT, lactate threshold; VCP, ventilatory compensation point.
Figure 2. Values and reliability of peak _VO2= _VE and peak
_VCO2= _VE (circulatory equivalents) in heart failure patients and
healthy controls. A, Peak _VO2= _VE in heart failure patients and
healthy controls. B, Peak _VCO2= _VE in heart failure patients
and healthy controls. C, CV% of peak _VO2= _VE and LT during slow,
medium, and fast ramp-incremental exercise tests in heart failure
patients. D, CV% of peak _VCO2= _VE and VCP during slow, medium
and fast ramp-incremental exercise tests in heart failure patients.
CHF indicates congestive heart failure; CV%, coefﬁcient of
variation; LT, lactate threshold; _VCO2, carbon dioxide output;
VCP, ventilatory compensation point; _VE, exhaled ventilation; _VO2,
oxygen uptake. *P<0.05; **P<0.0001.
Table 3. Peak Circulatory Equivalents ( _VO2= _VE and _VCO2= _VE)
in HF Patients and Controls Determined Using the X-Y Plot
Peak _VO2= _VE (mL/L) Peak _VCO2= _VE (mL/L)
Control (n=11, medium) 41.84.8 36.94.0
HF (n=24, medium ramp) 31.24.4* 28.73.8*
HF (n=18, different ramp protocols)
Slow ramp 31.94.2 29.23.5
Medium ramp 31.83.7 29.33.0
Fast ramp 31.03.7 29.03.1
Data are presented as meanSD.
*P<0.01 HF vs control for the same ramp protocol (medium).
HF indicates heart failure.
Figure 3. Regression and agreement analysis (Bland-Altman)
for LT and VCP estimation using X-Y plot and 9-panel plot. A,
Regression between _VO2 at LT (9-panel) and _VO2 at peak _VO2= _VE
(X-Y plot): r2=0.94; P<0.0001. B, Agreement plot of _VO2 at LT (9-
panel) and _VO2 at peak _VO2= _VE (X-Y plot): mean bias, 0.11 L/
min; 95% conﬁdence interval, 0.15, 0.07 L/min. C, Regres-
sion between _VO2 at VCP (9-panel) and _VO2 at peak _VCO2= _VE (X-Y
plot): r2=0.98, P<0.0001. D, Agreement plot of _VO2 at VCP (9-
panel) and _VO2 at peak _VCO2= _VE (X-Y plot): mean bias, 0.08 L/
min; 95% conﬁdence interval, 0.11, 0.05 L/min. LT indicates
lactate threshold; VCP, ventilatory compensation point.
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signiﬁcantly less variable than VCP from the 9-panel
(3.31.8% versus 8.74.2%; P<0.001; Figure 2D).
Agreement of Threshold Detection Between
Circulatory Equivalents and 9-Panel Methods
In all 35 participants, the _VO2 at which peak _VO2= _VE occurred
was very strongly correlated with, but was lower than, LT
(r2=0.94; P<0.0001; mean bias, 0.11 L/min; 95% conﬁ-
dence interval, 0.15, 0.07; Figure 3A and 3B). Similarly,
the _VO2 at which peak _VCO2= _VE occurred was very strongly
correlated with, but was lower than, VCP (r2=0.98; P<0.0001;
mean bias, 0.08 L/min; 95% conﬁdence interval, 0.11,
0.05; Figure 3C and 3D).
Discussion
CPET provides valuable information for the diagnosis, disease
severity, and prognosis of patients with HF.25–27 The strong
prognostic value of several CPET-derived variables for evalu-
ation of HF patients is well established, including LT, _VE= _VCO2
at LT or nadir, _VE= _VCO2 slope, _VO2peak, oscillatory breathing,
and end-tidal PO2 or PCO2. The value of peak _VO2= _VE and
peak _VCO2= _VE, however, is less well explored.
17 In this study,
we conﬁrmed previous ﬁndings that peak circulatory equiv-
alents distinguish between patients with HF and controls.17
We went on to establish that peak _VO2= _VE and peak _VCO2= _VE
values are strongly associated with (although not identical to)
LT and VCP, respectively. We also demonstrated that these
circulatory equivalents are less sensitive to different ramp-
incremental protocols in HF than noninvasive estimates of LT
and VCP using traditional criteria.9 Together, these data
provide a physiological interpretation of peak circulatory
equivalents and demonstrate stronger reliability of these
quantities across repeated exercise tests in the same patients
than physiological thresholds determined by traditional
methods. Circulatory equivalents therefore provide highly
robust, effort-independent, variables that reﬂect physiological
events known to hold very strong prognostic value in HF.
Circulatory equivalents may be a useful approach to simplify
the measurement, display, and interpretation of cardiopul-
monary exercise testing data.
Physiological Interpretation
Gas exchange during exercise assesses severity in HF better
than several other procedures.7,28,29 Variables relating pul-
monary gas exchange to ventilation independently discrimi-
nate HF severity better than echocardiography, resting
hemodynamics, and other exercise measurements.30,31 The
peak values of _VO2= _VE and _VCO2= _VE also hold the advantage
that they occur (in a large majority) during submaximal
aerobic exercise and therefore provide an effort-independent,
objective, assessment of disease severity. The dynamics and
peak values of circulatory equivalents are proposed to be
strongly reﬂective of the rate of pulmonary perfusion for a
given rate of ventilation, attributed to their dependence on the
product of pulmonary blood ﬂow and arteriovenous O2 and
CO2 concentration differences. In health and HF, both C(av)
O2 and C(va)CO2 differences widen progressively soon after
exercise onset.32,33 Hence, abnormality in _VO2= _VE or
_VCO2= _VE is likely to reﬂect abnormality in the ability to
increase and distribute pulmonary perfusion. Although these
variables cannot distinguish between hyperventilation that
reduces PaCO2, or deranged pulmonary perfusion that causes
high rates of ventilation with eucapnia (eg, high _VA= _Q and/or
VD/VT), the latter more commonly predominates; at least
when peak circulatory equivalents are >25% below normal.34
For these reasons, the peak values of _VO2= _VE and _VCO2= _VE
that occur during submaximal exercise are sensitive indices of
gas-exchange abnormality in HF that are likely to reﬂect a low
and/or poorly distributed pulmonary perfusion, rather than
excessive pulmonary ventilation per se, for example,
_VCO2= _VE ¼ k PaCO2  ð1 VD=VTÞ.
In this study, we demonstrated strong associations
between peak _VO2= _VE and LT (r
2=0.94) and between peak
_VCO2= _VE and VCP (r
2=0.98). Although there was a small, but
signiﬁcant, negative bias in these relationships (circulatory
equivalents detected LT and VCP slightly earlier in the
metabolic rate range), conceptually these variables should be
closely associated. The very strong association between _VCO2
and _VE over all metabolic rates preceding ventilatory
compensation means that, at LT, where metabolic CO2 output
is supplemented by CO2 evolved from buffering the associ-
ated acidosis, _VE begins to increase out of proportion to _VO2.
That is, unlike _VE= _VCO2, _VE= _VO2 increases more rapidly
immediately after LT than before it. The sub-LT relation
between _VE and _VO2 is hyperbolic. On the other hand, the
peak _VO2= _VE occurs at a point in the circulatory equivalent
plot where _VO2= _VE is approaching a vertical asymptote
(Figure 1B and 1D). Therefore, small deviations in data
measurement or sampling methods may inﬂuence the mea-
surements of the single peak value. This may be why peak
_VO2= _VE was consistently, by a small margin, lower in the
metabolic range than LT, and the 95% conﬁdence interval
spanned 125 mL/min (10% of _VO2peak) either side of this
mean. Peak _VO2= _VE is an objectively determined maximum,
whereas LT estimation by 9-panel requires interpretation of
several variables.24 As such, it is likely that LT estimation by
9-panel has greater internal validity and accuracy because
more variables are considered for its estimation. Neverthe-
less, it is currently unknown whether the differences between
peak _VO2= _VE and LT reﬂects the ability for more-accurate
noninvasive estimation of LT by circulatory equivalent or by 9-
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panel. Similarly, the onset of ventilatory compensation
(deﬁned as an increase in ventilation out of proportion to
CO2 output and a reduction in end-tidal PCO2) was typically
identiﬁed earlier by peak _VCO2= _VE in the X-Y plot than by 2
independent reviewers using the 9-panel report. Despite
these concerns, the greater reliability (lower coefﬁcient of
variation) of peak _VO2= _VE and peak _VCO2= _VE measurement is
encouraging.
Reliability of Circulatory Equivalents
Different ramp-incremental exercise protocols may inﬂuence
the ability to detect or alter the values of CPET-derived
variables, particularly LT, _VE peak, and _VCO2 peak. In this study,
however, altering the ramp-incrementation rate did not inﬂu-
ence peak _VO2 and _VE= _VCO2 at LT
21,35 or circulatory equiva-
lents in HF patients. During exercise, breath-by-breath
measurement of ventilation is less variable than gas exchange.
As such, using _VE as the denominator (circulatory equivalents)
tends to reduce variability compared with their inverse ratios
(ventilatory equivalents). Plotting circulatory equivalents
against one another, displayed on X-Y plot (rather than against
time, _VO2 or work rate), ampliﬁes abrupt changes in response
patterns, making the submaximally occurring peak _VO2= _VE and
_VCO2= _VE more readily identiﬁable. This may be another reason
why peak circulatory equivalents were less variable than LT and
VCP detection in this study, because they are less inﬂuenced by
subjective user assessment. Our data suggest that identiﬁca-
tion of physiological variables using peak circulatory equiva-
lents weremore reliable than traditional methods of LT and VCP
assessment across a wide range of ramp-incremental exercise
test durations in HF patients and therefore may provide the
basis for an improved assessment method.
It is important to note, however, that break points in
ventilatory equivalents observed at LT and VCP do not, by
necessity, have to be coincident with their minima (and thus
maxima in circulatory equivalents). Typically, breakpoints and
minima in ventilatory equivalents occur at the same metabolic
rate (eg, see Figure 1A and 1C). However, in patients with
very large VD/VT or _VA= _Q inequality, it is possible for
ventilatory equivalents to increase (not decrease) early in
exercise where the slope of the relationship between _VE and
_VCO2 has a negative intercept. Therefore, the association
between peak circulatory equivalents and LT or VCP that we
have identiﬁed here should be tested in a larger heteroge-
neous cohort.
Practical Implication
Whereas most modern metabolic carts measure the variables
required to calculate _VO2= _VE and _VCO2= _VE on a breath-by
breath basis, these ratios mathematically reduce to 1 FEO2
and FECO2, respectively (where FE, is the mixed expired gas
fractional concentration). Conceptually, the determinants of
mixed expired gas fractions are related to the balance between
delivery and clearance of each gas to the pulmonary
compartment: greater anatomic dead space, greater un- or
underperfused lung regions, and/or a greater ventilation of gas-
exchanging regions will each lower 1 FEO2 and FECO2.
Practically, 1 FEO2 and FECO2 have the advantage of being
simpler to measure than breath-by-breath gas exchange,
because only gas analyzers and a mixing chamber are required.
Therefore, using amixing chamber system and online X-Y plot of
circulatory equivalents to monitor the normalcy or otherwise of
gas exchange during exercise18 may simplify both the
measurement and interpretation of the normalcy or impairment
of gas-exchange responses in HF patients.
Limitations
We showed that noninvasive measurement of peak _VO2= _VE
was less variable in repeated testing that noninvasive
estimation of LT by 9-panel plot. However, we did not conduct
invasive measurements of the time course of blood lactate to
determine which threshold estimate (9-panel versus X-Y plot)
was more accurate. In addition, invasive measurements of
PaCO2 would allow us to distinguish the contributions of
pulmonary ventilation and/or pulmonary perfusion to the
peak _VO2= _VE and _VCO2= _VE values.
Plotting 2 “noisy” ratios such as _VO2= _VE and _VCO2= _VE
against each other exaggerates the inﬂuence of breath-by-
breath ﬂuctuations. Therefore, signal averaging is required (we
used a 90-second rolling average as previously identiﬁed17) to
discern the underlying patterns within the variables. This
inﬂuences the absolute values of the peak circulatory
equivalents, but improves the ability to identify them.
Nevertheless, we found no effect of this averaging procedure
on the values for LT and VCP, whereas the peak circulatory
equivalents remained a more-reliable assessment, suggesting
that this averaging procedure did not bias our conclusions.
Our experiments were performed only in HF patients with a
reduced EF. Therefore, whether our data are also applicable to
HF patients with a preserved EF is unclear.
It is possible that, the modest sample size inﬂuenced our
ability to detect differences in circulatory equivalents among
ramp protocols. However, using estimates of a clinically
meaningful difference in peak _VO2 of 1 mL/kg/min, or 6%
(based on a relative risk reduction of 5% from the HF-ACTION
cohort36), we estimate a statistical power (1-b) in this study
ranging 0.79 to 0.90 to identify a signiﬁcant difference in
circulatory equivalents among ramp-incrementation rates. On
balance, we think that a type II error is therefore unlikely.
We did not assess the dynamics of circulatory equivalents
in this article. Characteristics such as falling _VO2= _VE
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immediately at onset, rising _VO2= _VE and _VCO2= _VE at cessa-
tion, or “narrow loops” in the X-Y plot may have prognostic
value. A fall in _VO2= _VE and _VCO2= _VE at exercise onset is
sometimes observed in pulmonary hypertension, the opposite
to healthy participants, which might reﬂect a paradoxical
increase in _VA= _Q and/or VD/VT at exercise onset in these
patients. A rise in both _VO2= _VE and _VCO2= _VE at cessation is
characteristic of HF,17 which might reﬂect a sudden increase
in pulmonary perfusion given that thoracic pressure falls and
venous return is able to increase during active recovery. In an
attempt to quantify the entire proﬁle, we calculated the area
enclosed by the _VO2= _VE versus _VCO2= _VE loop as a potential
index of impaired circulatory equivalent dynamics, but the
variably incomplete recovery of these data among subjects
rendered this analysis unreliable. The dynamic proﬁle of the
circulatory equivalent plot, and not only peak values, deserve
further consideration for their utility in interpretation of CPET
data.
Conclusion
The circulatory equivalents, _VO2= _VE and _VCO2= _VE, by X-Y
plot are sensitive indices of gas-exchange abnormality
during submaximal exercise and can distinguish HF patients
from controls. The circulatory equivalents are likely to
reﬂect a low and/or poorly distributed pulmonary perfusion,
rather than excessive pulmonary ventilation per se. The _VO2
at which peak _VO2= _VE and peak _VCO2= _VE values occurred
were strongly associated with (although not identical to),
and were more reliable than, LT and VCP, respectively,
using traditional noninvasive assessment methods. In addi-
tion, peak _VO2= _VE and peak _VCO2= _VE values were not
affected by ramp-incrementation rate. Overall therefore,
peak circulatory equivalents are strongly related to LT and
VCP during exercise; they are reliable, sensitive, effort
independent, and uninﬂuenced by different exercise testing
protocols, making them useful objective cardiopulmonary
exercise testing indices for diagnosis and prognosis in HF
patients.
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